Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy and asthma.

Ira Finegold1

  • 1St Luke's Roosevel Hospital Center, New York City, USA.

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|June 24, 2003
PubMed
Summary
This summary is machine-generated.

Immunotherapy is the only available treatment to control and prevent allergic illness. Early consideration of immunotherapy offers effective, safe, and cost-efficient long-term clinical improvement for allergic and asthmatic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A brief history of allergen immunotherapy.

Allergy and asthma proceedings·2022
Same author

The American College of Allergy, Asthma & Immunology: An 80-year legacy of accomplishments (1942-2022), part 3: Events and achievements (2012-2022).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2022
Same author

Rhinitis 2020: A practice parameter update.

The Journal of allergy and clinical immunology·2020
Same author

Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2017
Same author

The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012.

Current opinion in allergy and clinical immunology·2013
Same author

Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2012
Same journal

IL-10 promoter polymorphisms (-1082G > A,-819C > Tand - 592 C > A) and pediatric asthma susceptibility in a Mauritanian population.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same journal

Clinical significance and effects of miR-431-5p in children with asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same journal

Diagnostic Model Construction of Mitochondrial-Mitophagy Related Genes and Their Regulatory Network and Potential Drug Discovery in Childhood Allergic Asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same journal

Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same journal

Exploring the Mechanism of Zhichuanling Oral Liquid in Treating Childhood Bronchial Asthma Based on Network Pharmacology and Experimental Verification.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same journal

Beyond BMI: A Three-Dimensional Integrative Framework of Morphology-Metabolism-Adipose Inflammation for Predicting Obesity-Related Asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
See all related articles

Area of Science:

  • Allergy and immunology
  • Clinical medicine

Background:

  • Immunotherapy is the sole immunologic treatment for controlling and preventing allergic conditions.
  • Current treatments often involve polypharmacy with potential adverse reactions.

Purpose of the Study:

  • To highlight the efficacy, safety, and cost-effectiveness of immunotherapy.
  • To advocate for the early integration of immunotherapy in treatment plans for allergic and asthmatic patients.

Main Methods:

  • Review of recent studies on immunotherapy effectiveness and safety.
  • Analysis of immunotherapy's role in managing allergic and asthmatic conditions.

Main Results:

  • Immunotherapy demonstrates effectiveness, safety, and cost-efficiency.

Related Experiment Videos

  • It offers a viable alternative to polypharmacy in managing allergic diseases.
  • Conclusions:

    • Immunotherapy should be considered early in treatment planning for selected allergic and asthmatic patients.
    • It provides preventive benefits and potentially long-lasting clinical improvement.